FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations

被引:117
作者
Wlodarska, I
Veyt, E
De Paepe, P
Vandenberghe, P
Nooijen, P
Theate, I
Michaux, L
Sagaert, X
Marynen, P
Hagemeijer, A
De Wolf- Peeters, C
机构
[1] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium
[2] Ghent Univ Hosp, Dept Pathol, Ghent, Belgium
[3] Stichting PAMM, Dept Pathol, Eindhoven, Netherlands
[4] Univ Clin UCL St Luc, Dept Pathol, Brussels, Belgium
[5] Katholieke Univ Leuven, Div Morphol & Mol Pathol, Dept Pathol, Louvain, Belgium
[6] Flanders Interuniv Inst Biotechnol, Louvain, Belgium
关键词
FOXP1; DLBCL; MALT; lymphoma; chromosome translocation;
D O I
10.1038/sj.leu.2403813
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The transcription factor Forkhead box protein P1 (FOXP1) is highly expressed in a proportion of diffuse large B-cell lymphoma (DLBCL). In this report, we provide cytogenetic and fluorescence in situ hybridization ( FISH) data showing that FOXP1 (3p13) is recurrently targeted by chromosome translocations. The genomic rearrangement of FOXP1 was identified by FISH in three cases with a t(3;14)(p13;q32) involving the immunoglobulin heavy chain (IGH) locus, and in one case with a variant t(2;3) affecting sequences at 2q36. These aberrations were associated with strong expression of FOXP1 protein in tumor cells, as demonstrated by immunohistochemistry (IHC). The cases with t(3p13) were diagnosed as DLBCL ( x 1), gastric MALT lymphoma ( x 1) and B-cell non-Hodgkin's lymphoma, not otherwise specified ( x 2). Further IHC and FISH studies performed on 98 cases of DLBCL and 93 cases of extranodal marginal zone lymphoma showed a high expression of FOXP1 in approximately 13 and 12% of cases, respectively. None of these cases showed, however, FOXP1 rearrangements by FISH. However, over-representation of the FOXP1 locus found in one additional case of DLBCL may represent another potential mechanism underlying an increased expression of this gene.
引用
收藏
页码:1299 / 1305
页数:7
相关论文
共 27 条
[1]  
[Anonymous], 2003, MITELMAN DATABASE CH
[2]  
Banham AH, 2005, CLIN CANCER RES, V11, P1065
[3]  
Banham AH, 2001, CANCER RES, V61, P8820
[4]   Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome [J].
Barrans, SL ;
Fenton, JAL ;
Banham, A ;
Owen, RG ;
Jack, AS .
BLOOD, 2004, 104 (09) :2933-2935
[5]   The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 [J].
Bennett, CL ;
Christie, J ;
Ramsdell, F ;
Brunkow, ME ;
Ferguson, PJ ;
Whitesell, L ;
Kelly, TE ;
Saulsbury, FT ;
Chance, PF ;
Ochs, HD .
NATURE GENETICS, 2001, 27 (01) :20-21
[6]   Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23) [J].
Borkhardt, A ;
Repp, R ;
Haas, OA ;
Leis, T ;
Harbott, J ;
Kreuder, J ;
Hammermann, J ;
Henn, T ;
Lampert, F .
ONCOGENE, 1997, 14 (02) :195-202
[7]   Forkhead-box transcription factors and their role in the immune system [J].
Coffer, PJ ;
Burgering, BMT .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (11) :889-899
[8]  
DAVIS RJ, 1994, CANCER RES, V54, P2869
[9]  
Dierlamm J, 2000, HEMATOL ONCOL, V18, P1
[10]   The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas [J].
Dierlamm, J ;
Baens, M ;
Wlodarska, I ;
Stefanova-Ouzounova, M ;
Hernandez, JM ;
Hossfeld, DK ;
De Wolf-Peeters, C ;
Hagemeijer, A ;
Van den Berghe, H ;
Marynen, P .
BLOOD, 1999, 93 (11) :3601-3609